Back To Search Instructions
Protocols
4 protocol(s) meet the specified criteria
Age Group: A
Disease Site: Cervix
Protocol No.TitleStatus
17404A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid TumorsOpen
187021AN OPEN-LABEL, MULTICENTER, PHASE II STUDY TO EVALUATE THE THERAPEUTIC ACTIVITY OF RO6874281, AN IMMUNOCYTOKINE, CONSISTING OF INTERLEUKIN-2 VARIANT (IL-2V) TARGETING FIBROBLAST ACTIVATION PROTEIN-A (FAP), IN COMBINATION WITH ATEZOLIZUMAB (ANTI-PD-L1), ADMINISTERED INTRAVENOUSLY, IN PARTICIPANTS WITH ADVANCED AND/OR METASTATIC SOLID TUMORSOpen
18801Non-pharmacologic approaches to relieve pain and symptom distress among diverse hospitalized cancer patientsOpen
18953Phase 1/2 Dose Escalation and Expansion Study Evaluating Safety, Tolerability, Pharmacokinetic, Pharmacodynamics and Anti-tumor Activity of PF-06873600 as a Single Agent and in Combination with Endocrine Therapy Open